We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Elaine Siegfried

Elaine C. Siegfried MD

Professor of Pediatrics and Dermatology, Saint Louis University; Chief, Division of Pediatric Dermatology, Cardinal Glennon Children’s Hospital, St. Louis, Missouri

Professor Elaine Siegfried is Director of the Division of Pediatric Dermatology at the Cardinal Glennon Children’s Hospital,Saint Louis University Health Sciences Center, USA, owner and Director of Kids Dermatology, St. Louis, USA.

Prof. Siegfried is a past President of the American Board of Dermatology, a founding member of the Pediatric Dermatology Research Alliance (PeDRA) and chair of the Emerging Practice Models Committee at the American Academy of Dermatology (AAD). She is also a member or fellow of a number of other professional organisations, including the Society for Pediatric Dermatology and the American Dermatological Association (ADA). She has volunteered her services for many years as a member of the scientific advisory boards for the National Eczema Association and the National Foundation for Ectodermal Dysplasia.

Prof. Siegfried has authored approximately 130 journal papers and 20 book chapters, and served as principle investigator for >50 clinical trials.

Disclosures

Dr. Siegfried reports the following:
  • AI Therapeutics – contracted research
  • ASLAN Pharmaceuticals – consultant fes
  • Boehringer Ingelheim - consulting fees
  • Incyte - consulting fees
  • Regeneron - consulting fees, honoraria; fees to SSM/SLU related to sponsoring clinical trials
  • Sanofi Genzyme - consulting fees, honoraria
  • UCBDSMB, consulting fees
  • Abbvie - consulting fees
  • Verrica - consulting fees, honoraria; fees to SSM/SLU related to sponsoring a clinical trial
  • Leo - consulting fees, DSMB
  • Novan - consulting fees; DSMB
  • Novartis - consulting fees
  • Pfizer - consulting fee; DSMB; grant funding to support 2020-2022 Peds Derm Fellow
  • Pierre Fabre - consulting fee; fees to SSM/SLU related to sponsoring a clinical trial
  • Janssen – PI, fees to SSM/SLU related to sponsoring a clinical trial
  • Lilly - fees to SSM/SLU related to sponsoring a clinical trial

DSMB = Data Safety Monitoring Board

Recent Contributions to PracticeUpdate:

  1. Treatment of Atopic Dermatitis With Weekly Dupilumab